RÉSUMÉ
Combinations of ribonucleases (RNases) are commonly used to digest RNA into oligoribonucleotide fragments prior to liquid chromatography-mass spectrometry (LC-MS) analysis. The distribution of the RNase target sequences or nucleobase sites within an RNA molecule is critical for achieving a high mapping coverage. Cusativin and MC1 are nucleotide-specific endoribonucleases encoded in the cucumber and bitter melon genomes, respectively. Their high specificity for cytidine (Cusativin) and uridine (MC1) make them ideal molecular biology tools for RNA modification mapping. However, heterogenous recombinant expression of either enzyme has been challenging because of their high toxicity to expression hosts and the requirement of posttranslational modifications. Here, we present two highly efficient and time-saving protocols that overcome these hurdles and enhance the expression and purification of these RNases. We first purified MC1 and Cusativin from bacteria by expressing and shuttling both enzymes to the periplasm as MBP-fusion proteins in T7 Express lysY/IqE. coli strain at low temperature. The RNases were enriched using amylose affinity chromatography, followed by a subsequent purification via a C-terminal 6xHIS tag. This fast, two-step purification allows for the purification of highly active recombinant RNases significantly surpassing yields reported in previous studies. In addition, we expressed and purified a Cusativin-CBD fusion enzyme in P. pastoris using chitin magnetic beads. Both Cusativin variants exhibited a similar sequence preference, suggesting that neither posttranslational modifications nor the epitope-tags have a substantial effect on the sequence specificity of the enzyme.
Sujet(s)
Endoribonucleases , Escherichia coli , Expression des gènes , Ribonucléases , Endoribonucleases/biosynthèse , Endoribonucleases/composition chimique , Endoribonucleases/génétique , Endoribonucleases/isolement et purification , Escherichia coli/génétique , Escherichia coli/métabolisme , Protéines recombinantes/biosynthèse , Protéines recombinantes/composition chimique , Protéines recombinantes/génétique , Protéines recombinantes/isolement et purification , Ribonucléases/biosynthèse , Ribonucléases/composition chimique , Ribonucléases/génétique , Ribonucléases/isolement et purificationRÉSUMÉ
An understanding of why hydrophilic interaction liquid chromatography gives a higher resolution for glycans than for glycoproteins would facilitate column improvements. Separations of the glycoforms of ribonuclease B compared to its released glycans were studied using a commercial hydrophilic interaction liquid chromatography column. The findings were used to devise a new hydrophilic interaction liquid chromatography column. For the commercial column, chromatograms and van Deemter plots showed that selectivity and efficiency are comparable factors in the higher resolution of the released glycans. The higher selectivity for the released glycans was associated with more water molecules displaced per added mannose. To investigate why, three-dimensional structures of the glycoprotein and the glycan were computed under chromatographic conditions. These showed that hydrogen bonding within the free glycan makes its topology more planar, which would increase contact with the bonded phase. The protein sterically blocks the hydrogen bonding. The more globular-shaped glycan of the glycoprotein suggests that a thicker bonded phase might improve selectivity. This was tested by making a column with a copolymer bonded phase. The results confirmed that selectivity is increased. The findings are possibly broadly relevant to glycoprotein analysis since the structural motif involved in internal hydrogen bonding is common to N-linked glycans of human glycoproteins.
Sujet(s)
Glycoprotéines/composition chimique , Polyosides/analyse , Ribonucléases/composition chimique , Conformation des glucides , Chromatographie en phase liquide , Glycoprotéines/isolement et purification , Glycoprotéines/métabolisme , Interactions hydrophobes et hydrophiles , Polyosides/métabolisme , Ribonucléases/isolement et purification , Ribonucléases/métabolismeRÉSUMÉ
The edible mushroom Agrocybe aegerita produces a ribotoxin-like protein known as Ageritin. In this work, the gene encoding Ageritin was characterized by sequence analysis. It contains several typical features of fungal genes such as three short introns (60, 55 and 69 bp) located at the 5' region of the coding sequence and typical splice junctions. This sequence codes for a precursor of 156 amino acids (~17-kDa) containing an additional N-terminal peptide of 21 amino acid residues, absent in the purified toxin (135 amino acid residues; ~15-kDa). The presence of 17-kDa and 15-kDa forms was investigated by Western blot in specific parts of fruiting body and in mycelia of A. aegerita. Data show that the 15-kDa Ageritin is the only form retrieved in the fruiting body and the principal form in mycelium. The immunolocalization by confocal laser scanning microscopy and transmission electron microscopy proves that Ageritin has vacuolar localization in hyphae. Coupling these data with a bioinformatics approach, we suggest that the N-terminal peptide of Ageritin (not found in the purified toxin) is a new signal peptide in fungi involved in intracellular routing from endoplasmic reticulum to vacuole, necessary for self-defense of A. aegerita ribosomes from Ageritin toxicity.
Sujet(s)
Agrocybe/génétique , Cytotoxines/génétique , Corps fructifères de champignon/métabolisme , Protéines fongiques/génétique , Mycelium/métabolisme , Ribonucléases/génétique , Agrocybe/métabolisme , Agrocybe/ultrastructure , Séquence d'acides aminés , Biologie informatique , Cytotoxines/biosynthèse , Cytotoxines/isolement et purification , Réticulum endoplasmique/métabolisme , Réticulum endoplasmique/ultrastructure , Exons , Corps fructifères de champignon/ultrastructure , Protéines fongiques/biosynthèse , Protéines fongiques/isolement et purification , Expression des gènes , Introns , Mycelium/ultrastructure , Cadres ouverts de lecture , Signaux de triage des protéines/génétique , Transport des protéines , Ribonucléases/biosynthèse , Ribonucléases/isolement et purification , Ribosomes/génétique , Ribosomes/métabolisme , Alignement de séquences , Similitude de séquences d'acides aminés , Vacuoles/métabolisme , Vacuoles/ultrastructureRÉSUMÉ
Fungi produce several toxins active against plants, animal or humans. Among them, ribotoxins are enzymes that specifically attack ribosomes irreparably compromising protein synthesis, useful as insecticides or as anticancer agents. Here, a novel ribotoxin from the edible mushroom Pleurotus ostreatus has been purified and characterized. This ribotoxin, named Ostreatin, is a specific ribonuclease releasing α-fragment when incubated with yeast or rabbit ribosomes. Ostreatin shows IC50 of 234 pM in rabbit reticulocyte lysate, and metal dependent endonuclease activity. Following the completion of Ostreatin primary structure, we ascertained that this toxin is homologous to Ageritin, the first ribotoxin-like protein from the basidiomycete Agrocybe aegerita, with which it shares 38.8% amino acid sequence identity. Ostreatin consists of 131 amino acid residues with an experimental molecular mass of 14,263.51 Da ([M+H+]+). Homology modeling revealed that Ostreatin and Ageritin share a similar fold in which the common catalytic triad is conserved. Purified Ostreatin lacks N-terminal and C-terminal peptides, which instead are present in the Ostreatin coding sequence. Such peptides are probably involved in protein sorting and for this they could be removed. Our findings confirm the presence of ribotoxin-like proteins in basidiomycetes edible mushrooms, that we propose as novel tool for biotechnological applications.
Sujet(s)
Corps fructifères de champignon/enzymologie , Mycotoxines/composition chimique , Pleurotus/enzymologie , Ribonucléases/composition chimique , Agaricales , Séquence d'acides aminés , Ascomycota/génétique , Séquence nucléotidique , Chromatographie sur gel , Activation enzymatique , Expression des gènes , Modèles moléculaires , Mycotoxines/génétique , Mycotoxines/isolement et purification , Mycotoxines/métabolisme , Conformation des protéines , Protéines recombinantes , Ribonucléases/génétique , Ribonucléases/isolement et purification , Ribonucléases/métabolisme , Spectrométrie de masse MALDI , Relation structure-activitéRÉSUMÉ
Members of the T2 extracellular ribonucleases family have long been reported as stress response proteins, often involved in host defence, in many different taxonomic groups. In particular, the human RNASET2 protein (hRNASET2) has been reported as an extracellular tumor suppressor protein, endowed with the ability to act as an "alarmin" signalling molecule following its expression and secretion in the tumor microenvironment by cancer cells and the subsequent recruitment and activation of cells belonging to the host innate immune system. Many in vitro and in vivo assays have been recently reported in support of the oncosuppressive role of hRNASET2: most of them relied on genetically engineered cell lines and the use of recombinant proteins from non-mammalian sources. In order to ensure a human-like glycosylation pattern, here we report for the first time the expression of recombinant hRNASET2 in the CHO-S cell line. We established a simple one-step chromatographic purification procedure that resulted in the production of 5 mg of endotoxin-free hRNASET2 per liter of culture, with a >95% purity degree. hRNASET2 expressed in CHO-S cells displayed a high degree of glycosylation homogeneity and a secondary structure content in agreement with that determined from the crystal structure. Indeed, recombinant hRNASET2 was active at both enzymatic and functional level, as stated by a biological activity assay. The availability of a pure, homogeneous recombinant human RNASET2 would provide a key tool to better investigate its non cell-autonomous roles in the context of cancer development and growth.
Sujet(s)
Expression des gènes , Ribonucléases , Protéines suppresseurs de tumeurs , Animaux , Cellules CHO , Cricetulus , Glycosylation , Humains , Protéines recombinantes , Ribonucléases/biosynthèse , Ribonucléases/génétique , Ribonucléases/isolement et purification , Protéines suppresseurs de tumeurs/biosynthèse , Protéines suppresseurs de tumeurs/génétique , Protéines suppresseurs de tumeurs/isolement et purificationRÉSUMÉ
The results of studies of a newly isolated Serratia species K-57 strain are presented. The strain is characterized by antiviral activity towards human influenza A/Aichi/2/68/H3N2, vaccinia, mouse smallpox, and herpes simplex-2 viruses. The detected characteristics of the strain, including the data on activities on nucleolytic enzymes, recommend it for the development of therapeutic and preventive antiviral drugs.
Sujet(s)
Antiviraux/pharmacologie , Protéines bactériennes/pharmacologie , Désoxyribonucléases/pharmacologie , Ribonucléases/pharmacologie , Serratia/composition chimique , Animaux , Antiviraux/isolement et purification , Protéines bactériennes/isolement et purification , Chlorocebus aethiops , Désoxyribonucléases/isolement et purification , Chiens , Herpèsvirus humain de type 2/effets des médicaments et des substances chimiques , Herpèsvirus humain de type 2/croissance et développement , Humains , Sous-type H3N2 du virus de la grippe A/effets des médicaments et des substances chimiques , Sous-type H3N2 du virus de la grippe A/croissance et développement , Cellules rénales canines Madin-Darby , Souris , Tests de sensibilité microbienne , Ribonucléases/isolement et purification , Virus de la vaccine/effets des médicaments et des substances chimiques , Virus de la vaccine/croissance et développement , Virus de la variole/effets des médicaments et des substances chimiques , Virus de la variole/croissance et développement , Cellules VeroRÉSUMÉ
A ribonuclease was purified from dry fruiting bodies of the wild edible mushroom Lepista personata (LPR) to 259-fold with a specific activity of 280 U/mg. The purification protocol involved ion-exchange chromatography on DEAE-cellulose, CM-cellulose and SP-sepharose, followed by size exclusion chromatography on Superdex 75. LPR is a homodimeric protein with a molecular weight of 27.8 kDa as determined by SDS-PAGE and by gel filtration. Three inner peptide sequences for LPR were obtained by LC-MS-MS analysis. It demonstrated the optimum pH of 4.0 and temperature optimum of 60°C. The specificity ribonuclease potencies order toward polyhomoribonucleotides was poly C > poly A > poly G > poly U. The ribonuclease inhibited HIV-1 reverse transcriptase with an IC50 of 0.53 µM.
Sujet(s)
Agaricales/enzymologie , Protéines fongiques/isolement et purification , Transcriptase inverse du VIH/antagonistes et inhibiteurs , Ribonucléases/isolement et purification , Agaricales/composition chimique , Agaricales/métabolisme , Stabilité enzymatique , Corps fructifères de champignon/composition chimique , Corps fructifères de champignon/enzymologie , Protéines fongiques/composition chimique , Transcriptase inverse du VIH/composition chimique , Concentration en ions d'hydrogène , Masse moléculaire , Ribonucléases/composition chimiqueRÉSUMÉ
Ageritin, a specific ribonuclease, damaging the largest rRNA in the highly conserved α-sarcin/ricin stem-loop (SRL) has been well characterized from edible mushroom Agrocybe aegerita. Given its peculiar characteristic, Ageritin is the prototype of a new ribotoxins family expressed in basidiomycetes. In this framework, we report the characterization of Met-Ageritin, an isoform of Ageritin with an additional N-terminal methionyl residue. This difference affects the enzymatic features of this toxin despite is able to release α-fragment when acting on yeast, rabbit or Trichoderma asperellum ribosomes. Met-Ageritin inhibits protein synthesis in vitro with an IC50â¯=â¯2.8â¯nM that is 21-fold lower than that of Ageritin, while not show endonuclease activity on DNA. Subsequently, we explored the antifungal activity of both isoforms against T. asperellum, pathogen for A. aegerita and Saccharomyces cerevisiae, used as eukaryotic model microorganism. The presence of an additional N-terminal methionyl residue in Met-Ageritin abolishes antifungal activity towards T. asperellum, while neither of two isoforms is able to inhibit the growth of S. cerevisiae. Overall, these data highlight the importance of the N-terminal region of this toxin that likely alters the conformational state of this enzyme considering the presence in this region of metal binding sites necessary for explicate enzymatic activity.
Sujet(s)
Agrocybe/composition chimique , Antifongiques/pharmacologie , Ribonucléases/pharmacologie , Antifongiques/composition chimique , Antifongiques/isolement et purification , Corps fructifères de champignon/composition chimique , Conformation des protéines , Ribonucléases/composition chimique , Ribonucléases/isolement et purificationRÉSUMÉ
Rapid detection of nucleic acids is integral to applications in clinical diagnostics and biotechnology. We have recently established a CRISPR-based diagnostic platform that combines nucleic acid pre-amplification with CRISPR-Cas enzymology for specific recognition of desired DNA or RNA sequences. This platform, termed specific high-sensitivity enzymatic reporter unlocking (SHERLOCK), allows multiplexed, portable, and ultra-sensitive detection of RNA or DNA from clinically relevant samples. Here, we provide step-by-step instructions for setting up SHERLOCK assays with recombinase-mediated polymerase pre-amplification of DNA or RNA and subsequent Cas13- or Cas12-mediated detection via fluorescence and colorimetric readouts that provide results in <1 h with a setup time of less than 15 min. We also include guidelines for designing efficient CRISPR RNA (crRNA) and isothermal amplification primers, as well as discuss important considerations for multiplex and quantitative SHERLOCK detection assays.
Sujet(s)
Systèmes CRISPR-Cas , Endonucleases/génétique , Acides nucléiques/analyse , Amorces ADN , Endonucleases/isolement et purification , Endonucleases/métabolisme , Humains , Leptotrichia/génétique , Techniques d'amplification d'acides nucléiques/méthodes , Acides nucléiques/génétique , Ingénierie des protéines/méthodes , , Protéines recombinantes/génétique , Protéines recombinantes/isolement et purification , Protéines recombinantes/métabolisme , Ribonucléases/génétique , Ribonucléases/isolement et purification , Ribonucléases/métabolisme , Flux de travaux , Virus Zika/génétique , Infection par le virus Zika/sang , Infection par le virus Zika/urineRÉSUMÉ
Ageritin is the first reported ribotoxin-like protein from basidiomycetes fungi. It can induce ribosomal integrity damage and translation block, and interferes with mitochondrial redox activity of some glioma and neuroblastoma cell lines. Herein, Ageritin has been investigated as a valuable neurotoxin towards either undifferentiated or retinoic acid (RA)-differentiated SH-SY5Y neuroblastoma cells showing a selective cell toxicity against undifferentiated cells. MTT and sulforhodamine B (SRB) assays highlighted that Ageritin markedly decreases the mitochondrial redox activity and viability of undifferentiated cells, meanwhile inducing evident morphological changes eliciting neuronal-like appearance in these cells. Data from lactate dehydrogenase release assay, cytofluorimetric analysis and caspase-3 enzymatic activity measurement suggest that Ageritin promotes cell death through a caspase-dependent apoptotic pathway. The Z-VAD-FMK caspase inhibitor was able to prevent this apoptotic pathway activation. Based on the interesting behaviour of Ageritin vs. SH-SY5Y cells, the development of a scale-up procedure to obtain the purified protein in larger amounts (yield 2.5 mg per 100 g) has been optimized.
Sujet(s)
Agaricales/composition chimique , Différenciation cellulaire/effets des médicaments et des substances chimiques , Extraits de plantes/pharmacologie , Ribonucléases/pharmacologie , Apoptose/effets des médicaments et des substances chimiques , Caspase-3/génétique , Caspase-3/métabolisme , Lignée cellulaire tumorale , Humains , Neurones/cytologie , Neurones/effets des médicaments et des substances chimiques , Neurones/métabolisme , Extraits de plantes/composition chimique , Extraits de plantes/isolement et purification , Ribonucléases/composition chimique , Ribonucléases/isolement et purificationRÉSUMÉ
Ribotoxins make up a group of extracellular rRNA endoribonucleases produced by ascomycetes that display cytotoxicity toward animal cells, having been proposed as insecticidal agents. Recently, the ribotoxin Ageritin has been isolated from the basidiomycetes Agrocybe aegerita (poplar mushroom), suggesting that ribotoxins are widely distributed among fungi. To gain insights into the protective properties of Ageritin against pathogens and its putative biotechnological applications, we have tested several biological activities of Ageritin, comparing them with those of the well-known ribotoxin α-sarcin, and we found that Ageritin displayed, in addition to the already reported activities, (i) antibacterial activity against Micrococcus lysodeikticus, (ii) activity against the tobacco mosaic virus RNA, (iii) endonuclease activity against a supercoiled plasmid, (iv) nuclease activity against genomic DNA, (v) cytotoxicity to COLO 320, HeLa, and Raji cells by promoting apoptosis, and (vi) antifungal activity against the green mold Penicillium digitatum. Therefore, Ageritin and α-sarcin can induce resistance not only to insects but also to viruses, bacteria, and fungi. The multiple biological activities of Ageritin could be exploited to improve resistance to different pathogens by engineering transgenic plants. Furthermore, the induction of cell death by different mechanisms turns these ribotoxins into useful tools for cancer therapy.
Sujet(s)
Agrocybe/composition chimique , Prolifération cellulaire/effets des médicaments et des substances chimiques , Cytotoxines/pharmacologie , Ribonucléases/pharmacologie , Anti-infectieux/pharmacologie , Lignée cellulaire tumorale , Tests de criblage d'agents antitumoraux , Humains , Tests de sensibilité microbienne , Micrococcus/effets des médicaments et des substances chimiques , Ribonucléases/isolement et purification , Virus de la mosaïque du tabac/effets des médicaments et des substances chimiquesRÉSUMÉ
RNA-DNA hybrids are common in chromosomal DNA. Persistent RNA-DNA hybrids result in replication fork stress, DNA breaks, and neurological disorders in humans. During replication, Okazaki fragment synthesis relies on frequent RNA primer placement, providing one of the most prominent forms of covalent RNA-DNA strands in vivo The mechanism of Okazaki fragment maturation, which involves RNA removal and subsequent DNA replacement, in bacteria lacking RNase HI remains unclear. In this work, we reconstituted repair of a linear model Okazaki fragment in vitro using purified recombinant enzymes from Bacillus subtilis We showed that RNase HII and HIII are capable of incision on Okazaki fragments in vitro and that both enzymes show mild stimulation by single-stranded DNA binding protein (SSB). We also showed that RNase HIII and DNA polymerase I provide the primary pathway for Okazaki fragment maturation in vitro Furthermore, we found that YpcP is a 5' to 3' nuclease that can act on a wide variety of RNA- and DNA-containing substrates and exhibits preference for degrading RNA in model Okazaki fragments. Together, our data showed that RNase HIII and DNA polymerase I provide the primary pathway for Okazaki fragment maturation, whereas YpcP also contributes to the removal of RNA from an Okazaki fragment in vitroIMPORTANCE All cells are required to resolve the different types of RNA-DNA hybrids that form in vivo When RNA-DNA hybrids persist, cells experience an increase in mutation rate and problems with DNA replication. Okazaki fragment synthesis on the lagging strand requires an RNA primer to begin synthesis of each fragment. The mechanism of RNA removal from Okazaki fragments remains unknown in bacteria that lack RNase HI. We examined Okazaki fragment processing in vitro and found that RNase HIII in conjunction with DNA polymerase I represent the most efficient repair pathway. We also assessed the contribution of YpcP and found that YpcP is a 5' to 3' exonuclease that prefers RNA substrates with activity on Okazaki and flap substrates in vitro.
Sujet(s)
Bacillus subtilis/enzymologie , Bacillus subtilis/métabolisme , Protéines bactériennes/métabolisme , ADN/métabolisme , Ribonucléases/métabolisme , Bacillus subtilis/génétique , Protéines bactériennes/génétique , Protéines bactériennes/isolement et purification , DNA polymerase I/métabolisme , Protéines recombinantes/génétique , Protéines recombinantes/isolement et purification , Protéines recombinantes/métabolisme , Ribonucléases/génétique , Ribonucléases/isolement et purificationRÉSUMÉ
In this study, two pathogenesis-related (PR) class 10 protein isoforms, ASPR-1 and ASPR-2, were purified from fresh roots of the Chinese medicinal plant Angelica sinensis (A. sinensis) using 80% ammonium sulfate precipitation, Sephadex G50 gel filtration chromatography, and DEAE-Sepharose ion-exchange chromatography. The molecular masses of ASPR-1 and ASPR-2 were estimated to be 16.66â¯kDa and 16.46â¯kDa, respectively, using sodium dodecylsulfate-polyacrylamide gel electrophoresis (SDS-PAGE). The isoforms are both glycoproteins containing glycosyl contents of 1.8% (ASPR-1) and 3.4% (ASPR-2). The two isoforms were predominantly present as monomers, but they partially dimerized in solution. The 15â¯N-terminal amino acids of ASPR-1 were determined to be GIQKTEVEAPSTVSA, with significant sequence homology to certain PR-10 proteins. ASPR-2 was also identified using matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF-MS) analysis to be a PR-10 protein. The isoforms both exhibited ribonuclease (RNase) activity, with ASPR-2 having higher specific activity (128.85 U mg-1) than ASPR-1 (68.67 U mg-1). The isoforms had the same optimal temperature of 50⯰C but different optimal pH values of 5.0 (ASPR-1) and 6.0 (ASPR-2). The RNase activities of the isoforms were both stable for 30â¯minâ¯at 50⯰C, rapidly decreasing at higher or lower processing temperatures. However, ASPR-1 retained higher residual activity (89.4%-80.9%) than ASPR-2 (74.3%-67.9%) at temperatures from 40⯰C to 60⯰C. These results provide additional information to enrich the current knowledge of poorly annotated A. sinensis proteins.
Sujet(s)
Angelica sinensis/composition chimique , Protéines végétales/composition chimique , Protéines végétales/isolement et purification , Racines de plante/composition chimique , Ribonucléases/composition chimique , Ribonucléases/isolement et purification , Angelica sinensis/métabolisme , Protéines végétales/métabolisme , Racines de plante/métabolisme , Isoformes de protéines/composition chimique , Isoformes de protéines/isolement et purification , Isoformes de protéines/métabolisme , Ribonucléases/métabolismeRÉSUMÉ
Malignant mesothelioma is an aggressive cancer that results from exposure to asbestos. The therapeutic options for this type of cancer are limited; therefore, the development of novel therapeutic agents is urgently required. Sialic acid-binding lectin isolated from Rana catesbeiana oocytes (cSBL) is a novel therapeutic candidate for cancer, which exhibits antitumor activity mediated through RNA degradation. In the present study, we evaluated the effect of cSBL in vitro and in vivo. Xenograft-competent H2452 and MSTO human mesothelioma cell lines were treated with cSBL, and the pathway by which cSBL induces apoptosis was analyzed. In vivo studies were performed using nude mice inoculated with one of the two cell lines, and the effects of cSBL and pemetrexed were monitored simultaneously. Furthermore, the pharmacological interactions between the three agents (pemetrexed, cisplatin and cSBL) were statistically assessed. It was demonstrated that cSBL treatments caused morphological and biochemical apoptotic changes in both cell lines. Caspase cascade analysis revealed that an intrinsic pathway mediated cSBL-induced apoptosis. The administration of cSBL significantly inhibited tumor growth in two xenograft models, without any adverse effects. Furthermore, the combination index and dose reduction index values indicated that the cSBL + pemetrexed combination showed the highest synergism, and thus potential for reducing dosage of each drug, compared with the other combinations, including the existing pemetrexed + cisplatin regimen. cSBL exerted prominent antitumor effects on malignant mesothelioma cells in vitro and in vivo, and showed favorable effects when combined with pemetrexed. These results suggest that cSBL has potential as a novel drug for the treatment of malignant mesothelioma.
Sujet(s)
Protéines d'amphibien/pharmacologie , Prolifération cellulaire/effets des médicaments et des substances chimiques , Lectines/pharmacologie , Mésothéliome/anatomopathologie , Ovule/composition chimique , Ribonucléases/pharmacologie , Protéines d'amphibien/isolement et purification , Animaux , Apoptose/effets des médicaments et des substances chimiques , Lignée cellulaire tumorale , Synergie des médicaments , Femelle , Humains , Techniques in vitro , Lectines/isolement et purification , Mâle , Souris de lignée BALB C , Souris nude , Pémétrexed/administration et posologie , Rana catesbeiana , Ribonucléases/isolement et purification , Perte de poids/effets des médicaments et des substances chimiques , Tests d'activité antitumorale sur modèle de xénogreffeRÉSUMÉ
The fungus Zymoseptoria tritici is the causal agent of Septoria Tritici Blotch (STB) disease of wheat leaves. Zymoseptoria tritici secretes many functionally uncharacterized effector proteins during infection. Here, we characterized a secreted ribonuclease (Zt6) with an unusual biphasic expression pattern. Transient expression systems were used to characterize Zt6, and mutants thereof, in both host and non-host plants. Cell-free protein expression systems monitored the impact of Zt6 protein on functional ribosomes, and in vitro assays of cells treated with recombinant Zt6 determined toxicity against bacteria, yeasts and filamentous fungi. We demonstrated that Zt6 is a functional ribonuclease and that phytotoxicity is dependent on both the presence of a 22-amino-acid N-terminal 'loop' region and its catalytic activity. Zt6 selectively cleaves both plant and animal rRNA species, and is toxic to wheat, tobacco, bacterial and yeast cells, but not to Z. tritici itself. Zt6 is the first Z. tritici effector demonstrated to have a likely dual functionality. The expression pattern of Zt6 and potent toxicity towards microorganisms suggest that, although it may contribute to the execution of wheat cell death, it is also likely to have an important secondary function in antimicrobial competition and niche protection.
Sujet(s)
Anti-infectieux/isolement et purification , Ascomycota/enzymologie , Maladies des plantes/microbiologie , Ribonucléases/isolement et purification , Triticum/microbiologie , Anti-infectieux/métabolisme , Ascomycota/pathogénicité , Mort cellulaire/effets des médicaments et des substances chimiques , Protéines fongiques/génétique , Protéines fongiques/isolement et purification , Protéines fongiques/métabolisme , Microbiote/effets des médicaments et des substances chimiques , Mycotoxines/génétique , Mycotoxines/isolement et purification , Mycotoxines/métabolisme , Feuilles de plante/microbiologie , Ribonucléases/génétique , Ribonucléases/métabolismeRÉSUMÉ
Human pancreatic ribonuclease (HPR) and bovine seminal ribonuclease (BS-RNase) are members of the RNase A superfamily. HPR is monomeric, whereas BS-RNase is dimeric. BS-RNase has strong antitumor and cytotoxic activities. However, HPR lacks cytotoxic activity as it is inactivated by intracellular cytosolic ribonuclease inhibitor (RI). Earlier, an RI-resistant cytotoxic variant of HPR, termed HPR-KNE was generated which contained three residues Lys7, Asn71 and Glu111 of HPR, known to interact with RI, mutated to alanine. In this study, we have engineered HPR to develop two dimeric RI-resistant molecules having anti-tumor activity. By incorporating two cysteines in HPR and HPR-KNE, we generated disulfide linked dimeric HPR, and a dimer of HPR-KNE, termed as HPR-D and HPR-KNE-D respectively. HPR-KNE-D was resistant towards inhibition by RI, and was found to be highly toxic to a variety of cells. On J774A.1 cells HPR-KNE-D was >375-fold more cytotoxic than HPR, and 15-fold more toxic than HPR-D. Further, on U373 cells HPR-KNE-D was >65-fold more cytotoxic than HPR, and 9-fold more toxic than HPR-D. The study demonstrates that combining dimerization and RI-resistance results in providing potent anti-tumor activity to HPR. The cytotoxic variants of HPR will be useful in designing protein therapeutics with low immunogenicity.
Sujet(s)
Antinéoplasiques/pharmacologie , Antienzymes/pharmacologie , Pancreatic ribonuclease/pharmacologie , Ribonucléases/pharmacologie , Animaux , Biocatalyse , Mort cellulaire/effets des médicaments et des substances chimiques , Lignée cellulaire , Dichroïsme circulaire , Clonage moléculaire , Humains , Souris , Protéines mutantes/isolement et purification , Pancreatic ribonuclease/isolement et purification , Ribonucléases/isolement et purificationRÉSUMÉ
In this study, we developed a multifunctional chromatographic medium by using iminodisuccinic acid (IDS) as ligand, γ-glycidoxypropyltrimethoxysilane (γ-GLDP) as spacer arm and silica as matrix. The medium was characterized by fourier transform infrared spectrometry (FT-IR). Binding capacity of IDS on chromatographic medium was determined by potentiometric titration. The effect of mass ratios (w/w) between silica and IDS on the medium synthesis was discussed. The optimal ratio of matrix, spacer arm and ligand was 1.5g: 2.0mL: 4.6g. Based on different chromatographic modes, protein mixtures of bovine serum albumin, ribonuclease and lysozyme were successfully separated with IDS-Silica column and IDS-Cu(II)-Silica column, respectively. To examine metal chelating behavior of IDS-Silica stationary phase, optimal geometries and related parameters of complexes formed by IDS with Fe3+, Cu2+, Ni2+, Zn2+, Co2+ and Ca2+ were achieved by quantum computing. The stabilities of the complexes were predicted according to the results of theoretical calculation. Sorption capacities of IDS-Silica stationary phase for metal ions were determined by using offline frontal chromatography (FC) combined with inductively coupled plasma atomic emission spectrometry (ICP-AES). A good agreement was found between simulating results and experimental observations. The order of chelating strength of IDS-Silica medium for metal ions was Fe3+>Cu2+>Ni2+>Zn2+>Co2+>Ca2+. Compared with IDA-Silica, Asp-Silica and Glu-Silica stationary phases, IDS-Silica displayed a stronger chelating property for metal ion.
Sujet(s)
Acides aminés/composition chimique , Chromatographie/méthodes , Silice/composition chimique , Succinates/composition chimique , Chélateurs/composition chimique , Métaux/composition chimique , Métaux/isolement et purification , Lysozyme/composition chimique , Lysozyme/isolement et purification , Ribonucléases/composition chimique , Ribonucléases/isolement et purification , Sérumalbumine bovine/composition chimique , Sérumalbumine bovine/isolement et purification , Silanes/composition chimique , Spectroscopie infrarouge à transformée de FourierRÉSUMÉ
Cationic ionic liquids-based surfactants (ILS), such as 4-methyl pyridinium bromide (CnPBr, where n=4,6,8), were used in preparation of polyacrylamide gels, sample buffer, and running buffer for cationic ILS polyacrylamide gel electrophoresis (ILS-PAGE). These ILS are liquids in the pure state and were selected for improved separation of ribonuclease b (Rib b) glycoforms in a single step and a protein mixture containing bovine serum albumin (BSA, pI-4.8, 66.5kDa), ovalbumin (Ova, pI-4.6, 44.3kDa), α-chymotrypsinogen (α-Chy, pI-8.8, 25.7kDa), myoglobin (Myo, pI-6.8, 16.9kDa), and cytochrome c (Cyt c, pI-10.0, 12.3kDa). Results acquired for Rib b glycoform separation by use of ILS were compared with conventional non-ILS surfactants-PAGE: sodium dodecylsulfate (SDS)-PAGE, cetyltrimethylammonium bromide (CTAB)-PAGE, and benzyldimethyl-n-hexadecylammonium chloride (16-BAC)-PAGE. A single protein band was observed with relatively short migration time in all the conventional PAGE techniques tested. In contrast, ILS-PAGE showed multiple bands with two distinct bands for Rib b protein. The two distinct bands of Rib b from ILS-PAGE were further analyzed using MALDI-MS. Examination of MALDI-MS spectral data revealed the presence of Rib b glycoforms. Furthermore, a two-dimensional isoelectric focusing (IEF)/SDS-PAGE map of Rib b protein revealed negative charge heterogeneity on the protein, which is a common observation for glycoproteins. This overall discovery greatly enhances the capability of using cationic ILS-PAGE for Rib b protein separation. Among all ILS tested, excellent protein separations were observed using C4PBr ILS at concentrations of 0.05% (w/v) in polyacrylamide gels, 0.01% (w/v) in protein sample buffer, and 0.1% (w/v) in running buffer. Under these optimum conditions, all other tested proteins were separated as sharp bands with good resolution.
Sujet(s)
Électrophorèse sur gel de polyacrylamide/méthodes , Liquides ioniques/composition chimique , Protéines/composition chimique , Ribonucléases/isolement et purification , Électrophorèse sur gel de polyacrylamide/instrumentation , Protéines/isolement et purification , Ribonucléases/composition chimique , Spectrométrie de masse MALDI , Tensioactifs/composition chimiqueRÉSUMÉ
The aim of this review is to cover most recent research on plant pathogenesis- and defenserelated proteins from latex-bearing medicinal plant Chelidonium majus (Papaveraceae) in the context of its importance for latex activity, function, pharmacological activities, and antiviral medicinal use. These results are compared with other latex-bearing plant species and recent research on proteins and chemical compounds contained in their latex. This is the first review, which clearly summarizes pathogenesisrelated (PR) protein families in latex-bearing plants pointing into their possible functions. The possible antiviral function of the latex by naming the abundant proteins present therein is also emphasized. Finally latex-borne defense system is hypothesized to constitute a novel type of preformed immediate defense response against viral, but also non-viral pathogens, and herbivores.
Sujet(s)
Antiviraux/composition chimique , Chelidonium/composition chimique , Latex/composition chimique , Protéines végétales/composition chimique , Alcaloïdes/composition chimique , Alcaloïdes/isolement et purification , Alcaloïdes/pharmacologie , Antiviraux/isolement et purification , Antiviraux/pharmacologie , Benzylisoquinoléines/composition chimique , Benzylisoquinoléines/isolement et purification , Benzylisoquinoléines/pharmacologie , Catechol oxidase/composition chimique , Catechol oxidase/isolement et purification , Catechol oxidase/pharmacologie , Chitinase/composition chimique , Chitinase/isolement et purification , Chitinase/pharmacologie , Endopeptidases/composition chimique , Endopeptidases/isolement et purification , Endopeptidases/pharmacologie , Lipoxygenase/composition chimique , Lipoxygenase/isolement et purification , Lipoxygenase/pharmacologie , Peroxidases/composition chimique , Peroxidases/isolement et purification , Peroxidases/pharmacologie , Protéines végétales/isolement et purification , Protéines végétales/pharmacologie , Ribonucléases/composition chimique , Ribonucléases/isolement et purification , Ribonucléases/pharmacologie , Réplication virale/effets des médicaments et des substances chimiquesRÉSUMÉ
Ribonucleases (RNases) catalyze the degradation of ribonucleic acid (RNA) into smaller nucleotides. RNases display angiogenic, neurotoxic, antitumor and immunosuppressive properties. In the present study, an extracellular RNase was successfully purified to homogeneity from a Bacillus sp. RNS3 (KX966412) by salting out at 0-50% ammonium sulphate saturation followed by the gel permeation (Sephadex G-100) chromatography. The multistep purification resulted in 10.4 fold purification of RNase with a yield of 3.12%. The activity of the purified RNase was found to be 2.02U/mg protein. The purified RNase was monomeric with a molecular weight of 66kDa. It exhibited Michalis-Menten kinetics parameters Kcat 7.92min-1 and Km 0.12mg/mL. The antiproliferative activity of the purified RNase was tested against an established Hep-2C (HeLa derived) cancer cell line in vitro. The purified RNase reduced the viability of the Hep-2C cells significantly with an IC50 value of 3.53µg/mL. The haemolytic activity of purified RNase was also evaluated and unfortunately, it showed a strong haemolytic activity towards human RBCs.